In agreement with previous RCTs [35,44,45] showing a safe profile of ESA in cardiac surgery, the two recent studies on anemia treatment in cardiac surgery by Ranucci and Spahn [36,37] did not report an excess of thrombotic events with erythropoietin. This evidence concerns the gene EPO and anemia.